Citation tools
"Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: results from a phase 2 randomised, parallel group, placebo-controlled trial." European Respiratory Journal
54.4
(2019):
1901030.
Web. 23 April. 2024.